These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 7827223)

  • 1. Omeprazole: short- and long-term safety.
    Yeomans ND
    Adverse Drug React Toxicol Rev; 1994; 13(3):145-56. PubMed ID: 7827223
    [No Abstract]   [Full Text] [Related]  

  • 2. [Omeprazole long-term therapy: how great is the risk of developing a carcinoid tumor?].
    Koop H
    Z Gastroenterol; 1988 Dec; 26(12):769-71. PubMed ID: 3149827
    [No Abstract]   [Full Text] [Related]  

  • 3. [What are the indications for proton pump inhibitors? R. Arnold, Marburg, elaborates on the clinical aspects of the controversy regarding lansoprazole. Interview by Gerrit Lichtenberg].
    Arnold R
    Fortschr Med; 1994 Jan; 112(1-2):44-5. PubMed ID: 8144120
    [No Abstract]   [Full Text] [Related]  

  • 4. Omeprazole, its isomers, and the carcinoid question.
    Daniels IR
    Lancet; 2001 Apr; 357(9264):1290-1. PubMed ID: 11421211
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evaluation of unexpected and toxic effects of omeprazole (Mopral) reported to the regional centers of pharmacovigilance during the first 22 postmarketing months].
    Castot A; Bidault I; Dahan R; Efthymiou ML
    Therapie; 1993; 48(5):469-74. PubMed ID: 8146827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vision and hearing disorders with omeprazole: the facts].
    Labenz J; Stolte M
    Leber Magen Darm; 1995 Jan; 25(1):6-8, 11. PubMed ID: 7877431
    [No Abstract]   [Full Text] [Related]  

  • 7. Omeprazole, hypergastrinemia, and gastric carcinoid tumors.
    Freston JW
    Ann Intern Med; 1994 Aug; 121(3):232-3. PubMed ID: 8017751
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of the long-term safety of omeprazole].
    Med Clin (Barc); 1990 Apr; 94(13):suppl 2. PubMed ID: 2355760
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of once-daily doses of omeprazole (40 and 20 mg) and placebo in the treatment of benign gastric ulcer: a multicenter, randomized, double-blind study.
    Valenzuela JE; Kogut DG; McCullough AJ; Colón Pagán JR; Shah U; Whipple J; Gilde LR; Simon TJ
    Am J Gastroenterol; 1996 Dec; 91(12):2516-22. PubMed ID: 8946978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of long-term treatment with lansoprazole and omeprazole on serum gastrin and the fundic mucosa.
    Arroyo Villarino MT; Lanas Arbeloa A; Esteva Díaz F; Ortego Fernández de Retana J; Sainz Samitier R
    Rev Esp Enferm Dig; 1997 May; 89(5):347-56. PubMed ID: 9190140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of antral peptides by administration of omeprazole to healthy men.
    Sumii M; Sumii K; Tari A; Yoshihara M; Haruma K; Kajiyama G
    Am J Gastroenterol; 1994 Nov; 89(11):2033-7. PubMed ID: 7942731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of short-term treatment with regular or high doses of omeprazole on the detection of Helicobacter pylori in bleeding peptic ulcer patients.
    Udd M; Miettinen P; Palmu A; Julkunen R
    Scand J Gastroenterol; 2003 Jun; 38(6):588-93. PubMed ID: 12825865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of omeprazole pre- and cotreatment on cerivastatin absorption and metabolism in man.
    Sachse R; Ochmann K; Rohde G; Mück W
    Int J Clin Pharmacol Ther; 1998 Oct; 36(10):517-20. PubMed ID: 9799053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short- and long-term omeprazole for the treatment and prevention of duodenal ulcer, and effect on Helicobacter pylori.
    Marzio L; Biasco G; Cifani F; DeFanis C; Falcucci M; Ferrini G; Grossi L; Iannetti G; Larcinese G; Lattanzio R
    Am J Gastroenterol; 1995 Dec; 90(12):2172-6. PubMed ID: 8540510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of omeprazole on the pharmacokinetics of paricalcitol in healthy subjects.
    Palaparthy R; Pradhan RS; Chan J; Rieser M; Chira T; Galitz L; Awni W; Williams LA
    Biopharm Drug Dispos; 2007 Mar; 28(2):65-71. PubMed ID: 17173278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter, double-blind, randomized controlled study of omeprazole versus ranitidine in the treatment of duodenal ulcer in Israel.
    Arber N; Avni Y; Eliakim R; Swissa A; Melzer E; Rachmilewitz D; Konikoff F
    Isr J Med Sci; 1994 Oct; 30(10):757-61. PubMed ID: 7960688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omeprazole: a comprehensive review.
    Massoomi F; Savage J; Destache CJ
    Pharmacotherapy; 1993; 13(1):46-59. PubMed ID: 8437967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of gastroduodenal damage with omeprazole in patients receiving continuous NSAIDs treatment. A double blind placebo controlled study.
    Bianchi Porro G; Lazzaroni M; Petrillo M; Manzionna G; Montrone F; Caruso I
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):43-7. PubMed ID: 9615264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis. The Lansoprazole Group.
    Castell DO; Richter JE; Robinson M; Sontag SJ; Haber MM
    Am J Gastroenterol; 1996 Sep; 91(9):1749-57. PubMed ID: 8792693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ["A defective public health office monitors health"].
    Günther K
    Leber Magen Darm; 1995 Jan; 25(1):39, 41. PubMed ID: 7877430
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.